文献速递生殖医学

胚胎植入前非整倍体遗传学检测对高龄且获卵数不超过三枚女性胚胎移植结局的影响

Effects of preimplantation genetic testing for aneuploidy on embryo transfer outcomes in women of advanced reproductive age with no more than three retrieved oocytes.
PubMed 文献 · Fertil Steril · 2024-12-12

本回顾性分析比较了高龄且卵巢储备减退(获卵数不超过三枚)女性中,选择胚胎植入前非整倍体遗传学检测(PGT-A)后行单胚胎复苏移植与未检测后行新鲜或复苏移植(1-2枚胚胎,第3或5天)的结局。PGT-A组每移植周期临床妊娠率(66.7% vs 12.4%)和活产率(57.1% vs 7.5%)显著更高,流产率(14.3% vs 40.0%)更低,但每取卵周期妊娠率和活产率总体相似。

要点

  • PGT-A组每移植周期临床妊娠率66.7%,非PGT-A组12.4%(aOR=11.474,95%CI 5.462-24.102)。
  • PGT-A组每移植周期活产率57.1%,非PGT-A组7.5%(aOR=13.065,95%CI 5.987-28.510)。
  • PGT-A组每移植周期流产率14.3%,非PGT-A组40.0%(aOR=0.142,95%CI 0.030-0.661)。

核心结论

  • PGT-A提高了高龄且获卵数低女性每移植周期的临床妊娠率和活产率,但未影响每取卵周期的相应率。

研究设计与样本

  • 回顾性分析,比较PGT-A组(选择PGT-A并随后行单胚胎复苏移植)与非PGT-A组(未检测胚胎并随后行新鲜或复苏移植1-2枚第3或5天胚胎)。
  • 共纳入298个PGT-A周期(来自230例患者,其中49例接受超过一个PGT-A周期)和429个非PGT-A周期(来自309例患者,其中89例接受超过一个此类周期),均来自单一中心,时间段为2019年4月至2023年6月。
  • 所有女性均存在卵巢储备减退且为高龄。

主要发现

  • PGT-A组移植率14.1%,非PGT-A组73.2%。
  • 每移植周期临床妊娠率:PGT-A组66.7%,非PGT-A组12.4%(aOR=11.474,95%CI 5.462-24.102)。
  • 每移植周期活产率:PGT-A组57.1%,非PGT-A组7.5%(aOR=13.065,95%CI 5.987-28.510)。
  • 每妊娠流产率:PGT-A组14.3%,非PGT-A组40.0%(aOR=0.142,95%CI 0.030-0.661)。
  • 总体妊娠率和活产率相似,PGT-A组达到活产所需周期数更少。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether preimplantation genetic testing for aneuploidy (PGT-A) benefits women of advanced reproductive age (≥38 years old) with a diminished ovarian reserve (not more than three retrieved oocytes). DESIGN: A retrospective analysis comparing two groups: (a) PGT-A group: women who chose PGT-A and subsequent single re-warmed embryo transfers and (b) non-PGT-A group: women who chose not to genetically test their embryos and underwent subsequent fresh or re-warmed embryo transfers of one to two embryos on days 3 or 5. SUBJECTS: Two hundred thirty patients underwent PGT-A therapy, with 49 of these individuals undergoing more than one PGT-A cycle. Meanwhile, 309 patients received non-PGT-A treatment, among whom 89 underwent more than one cycle of this type. Collectively, this study encompassed a total of 298 PGT-A cycles and 429 non-PGT-A cycles from a single center (April 2019-June 2023). All women had a diminished ovarian reserve and advanced reproductive age. EXPOSURE: The exposure variable was the use of PGT-A. MAIN OUTCOME MEASURES: The primary outcome was live birth rates (per cycle and retrieval). Secondary outcomes were clinical pregnancy rates (per cycle and retrieval) and miscarriage rates (per pregnancy and retrieval). RESULTS: Although PGT-A cycles had lower transfer rates (14.1% vs. 73.2%), they achieved significantly higher pregnancy (66.7% vs. 12.4%) (adjusted odds ratio [aOR] = 11.474; 95% confidence interval [CI], 5.462, 24.102) and live birth rates (57.1% vs. 7.5%) per transfer (aOR = 13.065; 95% CI, 5.987, 28.510). In addition, the PGT-A group had lower miscarriage rates (14.3% vs. 40.0%) (aOR = 0.142; 95% CI, 0.030, 0.661). However, overall pregnancy and live birth rates were similar, and the PGT-A group required fewer cycles for live birth. CONCLUSION: Although PGT-A improved clinical pregnancy and live birth rates per transfer cycle in women of advanced reproductive age with a low oocyte yield, it did not impact these rates per retrieval.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Ou Z, Liu N, Chen A, et al. Effects of preimplantation genetic testing for aneuploidy on embryo transfer outcomes in women of advanced reproductive age with no more than three retrieved oocytes. Fertil Steril. 2024. PMID: 39672364. doi:10.1016/j.fertnstert.2024.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。